250 employees
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
2021
$300M
from 1 investors over 1 rounds
ReNAgade Therapeutics raised $300M on May 23, 2023
Investors: MPM Capital